hotspot -WSS

hotspot

author：fashion 2025-08-26 10:54:19 - browse：343

Verve Therapeutics CEO Sekar Kathiresan Verve

SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines for rare, life-threatening diseases that generally affect small numbers of patients. But since Verve Therapeutics was founded in 2018, it’s had a wider aperture: using the molecular tools of genome editing to go after the most common cause of death in the world.

The plan, according to Verve CEO Sekar Kathiresan, is to edit out heart attacks for the millions of people at risk for severe cardiovascular disease. It’s a goal that’s more than a little audacious. There’s just one approved genome editing medicine, a treatment for sickle cell disease, and it only passed Food and Drug Administration review last month. Base editing, the CRISPR successor Verve uses to conduct its molecular surgery, is only a few years old.

“When we started, there were so many things that we were kind of going against the grain on,” Kathiresan told STAT at the J.P. Morgan Healthcare Conference in San Francisco this week. “In 2018, it was all about platforms, not about specific diseases and products, or taking this kind of idea for a large indication as opposed to cancer or rare disease. But we’ve always been motivated by a deep conviction in one simple research insight, which is that if your blood cholesterol is really low, lifelong, it is very hard to get a heart attack.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Feds fine Medicare Advantage plans for overcharging members

WSS

Australia’s approach to dialysis celebrates life

Antibiotic resistance and the global rise in human conflict

Study finds new variant for Parkinson’s in African populations

How a symptom of dementia informs our understanding of creativity

White House finalizes ITC's import ban of latest Apple Watches

NYU Langone launches private ChatGPT for its health care data

Wikipedia

hotspot

focus

ChatGPT in medicine: STAT answers readers' burning questions

Federal weight loss drug coverage is 30 years out of date

Medical records are filled with copy

GSK Flovent asthma inhalers replaced by authorized generics

What does generative AI mean for health care? We asked experts

NYU Langone launches private ChatGPT for its health care data

Malaria cases in Florida and Texas: Here’s what you need to know

What AAP's gender

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Complete sequence of Y chromosome published for first time

leisure time

JPM: CVS says Medicare Advantage patients are impacting profits

NYU Langone launches private ChatGPT for its health care data

Winners, losers from Medicare’s list of drugs subject to price talks

AdventHealth escalates lawsuit against insurance vendor Multiplan

How a scoliosis diagnosis changed the life of one young dancer

Chronically ill young patients struggle to find fertility info

Wikipedia

focus

entertainment

hotspot